Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Hepatitis
How do you determine when to start direct-acting antivirals in an unhoused person with chronic hepatitis C?
Related Questions
Can inflammatory arthritis develop in patients with a history of chronic hepatitis B?
When do you consider using a paramedian approach for a lumbar puncture?
How would you manage a patient with brucella melitensis abscess in whom surgery was initially deferred, developed worsening lower extremity numbness and weakness and MRI findings despite 1 month of combination therapy with ceftriaxone, rifampin, and doxycycline, and who is now readmitted to hospital following surgical washout?
What is your diagnostic approach to mild, chronic eosinophilia with AEC <1500?
How do you suggest incorporating POCUS into the evaluation of SSTIs, and do you use this as a means to guide initial antibiotic selection?
In what scenarios outside of cryptococcal meningitis do you use flucytosine as adjunctive antifungal therapy?
Do you have any concerns about using long-acting cabotegravir/rilpivirine in obese patients with HIV?
Under what circumstances do you recommend the chikungunya vaccine for travelers to areas without a current outbreak but with elevated risk, especially for extended stays?
Do you recommend immunomodulating treatments such as steroids or IVIG for West Nile Virus neuroinvasive disease?
For patients with spinal hardware infections, in what circumstances do you recommend 12 weeks over 6 weeks of antimicrobial therapy?
